Key Features

  • AI- supported prostate segmentation and volume
  • Lesion segmentation
  • PI-RADS v2.1 scoring support
  • Structured report
  • Volumes and risk scores

General Information

Product name

Prostate Intelligence™

Subspeciality

Abdomen

Modality

MR

Disease targeted

Prostate cancer

Main task

Not specified

Technical Specifications

Population

Prostate MRI scans with suspicion of prostate cancer, males >21 years

Patient population age

Not specified

Input

MRI, T2, DWI, DCE (optional)

Input format

DICOM

Output

Segmentation overlay, RTSTRUCT export for biopsy and 3D vizualization, structured report with key images, volumes and risk score

Output format

DICOM

Integration

Integration in standard reading environment (PACS)

Deployment

Cloud-based, Locally on dedicated hardware

Trigger for analysis

Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click

Processing time

1 - 10 minutes

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIb

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

05-2021

AI Platforms

Blackford Analysis, Deepc, Ferrum Health, Sectra, TeraRecon

Resellers

Aplicaciones Tecnológicas Fisica, HCK Healthcare Konnect, Medical Horizons, OpenRad

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Pay-per-use, Subscription

Based on

Number of analyses, Number of installations

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study

Other Articles

Other

View

Abstract: Multi-stage AI analysis system to support prostate cancer diagnostic imaging

Other

View

Abstract: P9: AI for prostate MRI: results from a large multicentre, multi-vendor external validation study

Source: vendor | First published: Jun 6, 2024 | Last updated: Jul 9, 2025